Evolent Health (EVH) Price to FCF (2015 - 2026)

Evolent Health has reported Price to FCF for 12 years, with the latest figure at 37.92 in Q2 2026.

• On a quarterly basis, Price to FCF fell 12.06% year-over-year to 37.92 in Q2 2026; TTM through Jun 2026 was 25.18, a 220.14% increase from a year earlier, with the FY2025 full-year figure at 93.91, up 143.88% from the prior year.
• Price to FCF was 37.92 for Q2 2026 at Evolent Health, down from 34.7 in the prior quarter.
• The five-year high for Price to FCF was 635.77 in Q2 2022, with the low at 8700.06 in Q1 2024.
• Average Price to FCF over 5 years is 487.45, with a median of 34.27 recorded in 2026.
• The sharpest annual moves came in 2022 and 2024: Price to FCF soared 1128.56% in 2022, then sank 3952.26% in 2024.
• Over 5 years, Price to FCF stood at 124.97 in 2022, then slumped by 63.39% to 45.75 in 2023, then slumped by 188.53% to 40.51 in 2024, then soared by 126.86% to 10.88 in 2025, then sank by 448.47% to 37.92 in 2026.
• The last three Price to FCF figures came in at 37.92 (Q2 2026), 34.7 (Q1 2026), and 10.88 (Q4 2025), per Business Quant data.